Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40135-014-0043-7 http://scihub22266oqcxt.onion/10.1007/s40135-014-0043-7 C4196268!4196268!25328857     free     free     free       Curr+Ophthalmol+Rep 2014 ; 2 (3): 81-90 Nephropedia Template TP {{tp|p=25328857|t=2014. Regenerative Cell Therapy for Corneal Endothelium |pdf=|usr=}}{{25328857}} gab.com Text Regenerative Cell Therapy for Corneal Endothelium JO: Curr Ophthalmol Rep http://www.kidney.de/pget.php?&tw=1&pmid=25328857 #FOAvip Endothelial cell dysfunction as in Fuchs dystrophy or pseudophakic bullous keratopathy, and the limited regenerative capacity of human corneal endothelial cells (HCECs), drive the need for corneal transplant. In response to limited donor corneal availability, significant effort has been directed towards cell therapy as an alternative to surgery. Stimulation of endogenous progenitors, or transplant of stem cell-derived HCECs or in vitro-expanded, donor-derived HCECs could replace traditional surgery with regenerative therapy. Ex vivo expansion of HCECs is technically challenging, and the basis for molecular identification of functional HCECs is not established. Delivery of cells to the inner layer of the human cornea is another challenge: different techniques, from simple injection to artificial corneal scaffolds, are being investigated. Despite remaining questions, corneal endothelial cell therapies, translated to the clinic, represent the future for the treatment of corneal endotheliopathies. Twit Text FOAVip Regenerative Cell Therapy for Corneal Endothelium ????Curr Ophthalmol Rep http://www.kidney.de/pget.php?&tw=1&pmid=25328857 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25328857 #FOAvip English Wikipedia <ref>{{Cite pmid|25328857}}</ref> Regenerative Cell Therapy for Corneal Endothelium #MMPMID25328857 Bartakova A; Kunzevitzky NJ; Goldberg JL Curr Ophthalmol Rep 2014[Sep]; 2 (3): 81-90 PMID25328857show ga Endothelial cell dysfunction as in Fuchs dystrophy or pseudophakic bullous keratopathy, and the limited regenerative capacity of human corneal endothelial cells (HCECs), drive the need for corneal transplant. In response to limited donor corneal availability, significant effort has been directed towards cell therapy as an alternative to surgery. Stimulation of endogenous progenitors, or transplant of stem cell-derived HCECs or in vitro-expanded, donor-derived HCECs could replace traditional surgery with regenerative therapy. Ex vivo expansion of HCECs is technically challenging, and the basis for molecular identification of functional HCECs is not established. Delivery of cells to the inner layer of the human cornea is another challenge: different techniques, from simple injection to artificial corneal scaffolds, are being investigated. Despite remaining questions, corneal endothelial cell therapies, translated to the clinic, represent the future for the treatment of corneal endotheliopathies. äRegenerative Cell Therapy for Corneal Endothelium (epmc).pdf DeepDyve Pubget Overpricing